Mono-sulfonated tetrazolium salt based NAD(P)H detection reagents suitable for dehydrogenase and real-time cell viability assays

Analytical Biochemistry

Volumn 509, Issue , 2016, Pages 33-40

  Zhang, Wei ^a,c   Zhu, Min ^a   Wang, Feng ^a   Cao, Danhui ^a   Ruan, Jennifer Jin ^b   Su, Weike ^a   Ruan, Benfang Helen ^a  

^a ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

^b Hangzhou Jennifer Biotech Inc   (China)

^c ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Cell proliferation; Cell toxicity; Dehydrogenase; High through put screening; Mono sulfonated tetrazolium salt; NAD(P)H assay

Indexed keywords

AMINES; CELL PROLIFERATION; CELLS; SILICA; SILICA GEL; TOXICITY;

CELL TOXICITY; DEHYDROGENASE; GLUTAMATE DEHYDROGENASE; HIGH-THROUGHPUT SCREENING; NAD(P)H; OXIDATIVE DEAMINATION; REAL TIME CELL VIABILITIES; THIOREDOXIN REDUCTASE INHIBITORS;

CYTOLOGY;

DACTINOMYCIN; GLUTAMATE DEHYDROGENASE; GLUTAMIC ACID; GLUTAMINASE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SILICA GEL; TETRAZOLIUM; THIOREDOXIN REDUCTASE; ESCHERICHIA COLI PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; CELL VIABILITY ASSAY; ENZYME ACTIVITY; ESCHERICHIA COLI; OXIDATION; PRIORITY JOURNAL; SPECTROSCOPY; STORAGE TEMPERATURE; A-549 CELL LINE; CELL SURVIVAL; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; SYNTHESIS;

A549 CELLS; CELL SURVIVAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GLUTAMATE DEHYDROGENASE; NADP; TETRAZOLIUM SALTS;

EID: 84978154018     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2016.06.026     Document Type: Article

References (24)

1. +/NADPH in cellular functions and cell Death: regulation and Biological Consequences. Antioxid. Redox. Sign 10 (2007), 179–206, 10.1089/ars.2007.1672 PMID: 18020963.
2. [2] Tsang, Y.H., Dogruluk, T., Tedeschi, P.M., Wardwell-Ozgo, J., Lu, H., Espitia, M., Nair, N., Minelli, R., Chong, Z., Chen, F., Chang, Q.E., Dennison, J.B., Dogruluk, A., Li, M., Ying, H., Bertino, J.R., Gingras, M.C., Ittmann, M., Kerrigan, J., Chen, K., Creighton, C.J., Eterovic, K., Mills, G.B., Scott, K.L., Functional annotation of rare gene aberration drivers of pancreatic cancer. Nat. Commun. 7 (2016), 10500–10510, 10.1038/ncomms10500 PMID: 26806015.
3. [3] Halliwell, B., Drug antioxidant effects. A basis for drug selection?. Drugs 42 (1991), 569–605 PMID: 1723362.
4. [4] Raap, A.K., Studies on the phenazine methosulphate-tetrazolium salt capture reaction in NAD(P)+-dependent dehydrogenase cytochemistry. III. The role of superoxide in tetrazolium reduction. Histochem. J. 15 (1983), 977–986 PMID: 6315642.
5. [5] Weinberg, S.E., Chandel, N.S., Targeting mitochondria metabolism for cancer therapy. Nat. Chem. Biol. 11 (2015), 9–15, 10.1038/nchembio.1712 PMID: 25517383.
6. [6] Hussain, M.M., Zannis, V., Plaitakis, A., Characterization of glutamate dehydrogenase isoproteins purified from the cerebellum of normal subjects and patients with degenerative neurological disorders, and from human neoplastic cell lines. J. Biol. Chem. 264 (1989), 20730–20735 PMID: 2573605.
7. [7] Couée, I., Tipton, K.F., The inhibition of glutamate dehydrogenase by some antipsychotic drugs, Biochem. Pharmacol 39 (1990), 827–832 PMID: 2310408.
8. [8] Whitelaw, B.S., Robinson, M.B., Inhibitors of glutamate dehydrogenase block sodium-dependent glutamate uptake in rat brain membranes. Front. Endocrinol. (Lausanne) 4 (2013), 123–131, 10.3389/fendo.2013.00123 PMID: 24062726.
9. [9] Fahien, L.A., MacDonald, M.J., Kmiotek, E.H., Mertz, R.J., Fahien, C.M., Regulation of insulin release by factors that also modify glutamate dehydrogenase. J. Biol. Chem. 263 (1988), 13610–136144 PMID: 3047128.
10. [10] Li, C., Allen, A., Kwagh, J., Doliba, N.M., Qin, W., Najafi, H., Collins, H.W., Matschinsky, F.M., Stanley, C.A., Smith, T.J., Green Tea Polyphenols Modulate Insulin Secretion by Inhibiting Glutamate Dehydrogenase. J. Biol. Chem. 281 (2006), 10214–10221, 10.1074/jbc. M5127922 00 PMID: 16476731.
11. [11] Amaral, A.U., Cecatto, C., Castilho, R.F., Wajner, M., 2-Methylcitric Acid Impairs Glutamate Metabolism and Induces Permeability Transition in Brain Mitochondria. J. Neurochem., 2016, 10.1111/jnc.13544 PMID: 26800654.
12. [12] Yoon, H.Y., Hwang, S.H., Lee, E.Y., Kim, T.U., Cho, E.H., Cho, S.W., Effects of ADP on different inhibitory properties of brain glutamate dehydrogenase isoproteins by perphenazine. Biochimie 83 (2001), 907–913 PMID: 11698113.
13. [13] Couée, I., Tipton, K.F., Inhibition of ox brain glutamate dehydrogenase by perphenazine. Biochem. Pharmacol. 39 (1990), 1167–1173 PMID: 2322301.
14. [14] Altman, F.P., Tetrazolium salts and formazans. Prog. Histochem. Cytochem 9 (1976), 1–56 PMID: 792958.
15. [15] Otero, A.J., Rodríguez, I., Falero, G., 2, 3, 5-Triphenyi Tetrazolium Chloride (TTC) reduction as exponential growth phase marker for mammalian cells in culture and for myeloma hybridization experiments. Cytotechnology 6 (1991), 137–142 PMID: 1367407.
16. [16] Vistica, D.T., Skehan, P., Scudiero, D., Monks, A., Pittman, A., Boyd, M.R., Tetrazolium-based Assays for Cellular Viability: A Critical Examination of Selected Parameters Affecting Formazan Production. Cancer Res. 51 (1991), 2515–2520 PMID: 2021931.
17. [17] De, N.M., Eziefula, A.C., Othieno, L., Mbabazi, E., Nabukeera, D., Ssemmondo, E., Gonahasa, S., Tumwebaze, P., Diliberto, D., Maiteki-Sebuguzi, C., Staedke, S.G., Drakeley, C., Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda. Malar. J. 12 (2013), 210–220, 10.1186/1475-2875-12-210 PMID: 23782846.
18. [18] Ishiyama, M., Miyazono, Y., Sasamoto, K., Ohkura, Y., Ueno, K., A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 44 (1997), 1299–1305 PMID: 18966866.
19. [19] Ostrovskaya, V.M., Lushina, O.T., Dziomko, V.M., Davydovskaya, J.A., Method for preparing 2H-tetrazolium chloride and 2H-tetrazolium chloride hydrochloride. United States Patent No. 4143049, 1979, 1–5 http://www.freepatentsonline.com/4143049.html.
20. [20] Ludolphy, E., Notiz über eine Tetrazoliumverbindung der Pyrimidinreihe. Chem. Ber. 84 (1951), 385–387, 10.1002/cber.19510840408.
21. [21] Botman, D., Tigchelaar, W., Van Noorden, C.J.F., Determination of Glutamate Dehydrogenase Activity and Its Kinetics in Mouse Tissues using Metabolic Mapping (Quantitative Enzyme Histochemistry). J. Histochem. Cytochem 62 (2014), 802–812, 10.1369/0022155414549071.
22. [22] Yang, C., Sudderth, J., Dang, T., Bachoo, R.M., McDonald, J.G., DeBerardinis, R.J., Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res. 69 (2009), 7986–7993, 10.1158/0008-5472.CAN-09-2266 PMID: 19826036.
23. [23] Zhao, R., Masayasu, H., Holmgren, A., Ebselen: A substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 8579–8584, 10.1073/pnas.122061399 PMID: 12070343.
24. [24] Li, M., Li, C., Allen, A., Stanley, C.A., Smith, T.J., The structure and allosteric regulation of glutamate dehydrogenase. Neurochem. Int. 59 (2011), 445–455, 10.1016/j.neuint.2010.10.017.